Latest available resultsQuarter ended July 5, 202610-Q · August 11, 2026
Filed with the SECREVVITY, INC.
RVTYHealthcare
Next reportOctober 26, 2026pre-market · Analyst forecast 1.319 $/share
Revenue
$729.69M
▲ +1.3% vs prior year% YoY
Net income
$51.82M
▼ -3.9% vs prior year% YoY
EPS
0.47$
▲ +2.2% vs prior year% YoY
Net margin
7.1%
▼ -0.4 percentage points vs prior year pp YoY
Revenue▲ +1.3 %
Margins (% of revenue)GrossOperatingNet
Net income▼ -3.9 %
EPS▲ +2.2 %
View financial tableQuarter ended July 5, 2026
| Metric | Value | Context |
|---|---|---|
| Operations | ||
| Revenue | $729.69M | |
| Gross profit | $416.87M | 57.1 % |
| Operating income | $89.32M | 12.2 % |
| Net income | $51.82M | 7.1 % |
| R&D | $48.97M | 6.7 % |
| EPS (diluted) | 0.47 $ | |
| Balance sheet | ||
| Assets | $12.05B | |
| Liabilities | $4.82B | |
| Equity | $7.23B | |
| Cash | $1.02B | |
| Capital | ||
| Shares outstanding | 111.59M | as of 2026-08-06 |
| Public float | — | |